Prestige Consumer Healthcare
PBH
#4654
Rank
HK$17.92 B
Marketcap
HK$378.47
Share price
0.75%
Change (1 day)
-20.28%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2026 (TTM): HK$28.04

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is HK$28.17. In 2025 the company made an earnings per share (EPS) of HK$29.90 a decrease over its 2024 EPS that were of HK$33.74.

EPS history for Prestige Consumer Healthcare from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$28.04-6.22%
2025HK$29.90-11.4%
2024HK$33.74-367.08%
2023-HK$12.63-138.33%
2022HK$32.9611.7%
2021HK$29.5113.6%
2020HK$25.97-651.67%
2019-HK$4.71-148.78%
2018HK$9.65-83.29%
2017HK$57.76437.23%
2016HK$10.75-34.13%
2015HK$16.3252.94%
2014HK$10.67-8.11%
2013HK$11.61
2011HK$6.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.54 143.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
HK$53.05 88.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$52.26 85.52%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.96-78.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$24.47-13.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
HK$48.50 72.14%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
HK$18.13-35.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$25.09-10.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
-HK$232.43-925.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
HK$9.57-66.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel